Bionik Laboratories Corp.·4

Oct 15, 5:02 PM ET

Russo Richard Paul Jr 4

4 · Bionik Laboratories Corp. · Filed Oct 15, 2021

Insider Transaction Report

Form 4
Period: 2021-10-14
Russo Richard Paul Jr
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-10-14+80,00080,000 total
    Exercise: $2.10Exp: 2028-10-14Common Stock, par value $0.001 (80,000 underlying)
Footnotes (1)
  • [F1]50% of the options vest as follows: 10,000 on the date of grant; 10,000 on October 14, 2022; 10,000 on October 14, 2023; and 10,000 on October 14, 2024. The other 50% of the options vest based on performance goals to be set for each of the first three years after grant.

Documents

1 file
  • 4
    tm2127621d5_4.xmlPrimary

    OWNERSHIP DOCUMENT